• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human ret proto-oncogene mapped to chromosome 10q11.2.

作者信息

Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, Fertitta A, Carrano A V, Nagao M

机构信息

Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.

出版信息

Oncogene. 1989 Dec;4(12):1519-21.

PMID:2687772
Abstract

Using cosmid clones derived from human ret protooncogene as probes, we determined its chromosome localization by fluorescence in situ hybridization. Two overlapping clones, cret-1 and -2, which were cloned using the most 5' part of human ret proto-oncogene cDNA, hybridized to chromosome 10q11.2. Sixty-three and 52% of the grains obtained by cret-1 and -2, respectively, were localized to the same site. No other specific hybridization site was observed. From these data, we assigned the site of ret proto-oncogene to chromosome 10q11.2, where the possible locus responsible for multiple endocrine neoplasia type 2A (MEN2A) was mapped by linkage analysis using interstitial retinol binding protein cDNA and D10S5. These findings suggest that ret proto-oncogene might be a suitable probe for approaching the MEN2A locus.

摘要

相似文献

1
Human ret proto-oncogene mapped to chromosome 10q11.2.
Oncogene. 1989 Dec;4(12):1519-21.
2
Tight linkage of the ret proto-oncogene with the multiple endocrine neoplasia type 2A locus.
Jpn J Clin Oncol. 1991 Jun;21(3):149-52.
3
The physical map of the human RET proto-oncogene.人类RET原癌基因的物理图谱。
Oncogene. 1995 Nov 2;11(9):1737-43.
4
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC.
Oncogene. 1991 Feb;6(2):339-42.
5
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.2A型多发性内分泌腺瘤病中RET原癌基因的种系突变。
Nature. 1993 Jun 3;363(6428):458-60. doi: 10.1038/363458a0.
6
The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2.
Genes Chromosomes Cancer. 1994 Sep;11(1):51-7. doi: 10.1002/gcc.2870110108.
7
A new polymorphism in the ret protooncogene (RET).原癌基因RET中的一种新的多态性。
Nucleic Acids Res. 1991 Oct 25;19(20):5795. doi: 10.1093/nar/19.20.5795.
8
Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease.常染色体显性遗传性先天性巨结肠症中RET原癌基因的紧密连锁及缺失突变边界
Hum Mol Genet. 1993 Nov;2(11):1803-8. doi: 10.1093/hmg/2.11.1803.
9
A novel polymorphism in the coding sequence of the human RET proto-oncogene.
Hum Genet. 1994 Nov;94(5):579-80. doi: 10.1007/BF00211034.
10
Structural analysis of the human ret proto-oncogene using exon trapping.利用外显子捕获技术对人类原癌基因ret进行结构分析。
Oncogene. 1993 Sep;8(9):2575-82.

引用本文的文献

1
Pathogenesis and Management Strategies in Radioiodine-Refractory Differentiated Thyroid Cancer: From Molecular Mechanisms Toward Therapeutic Approaches: A Comprehensive Review.放射性碘难治性分化型甲状腺癌的发病机制与治疗策略:从分子机制到治疗方法的全面综述
J Clin Med. 2024 Nov 26;13(23):7161. doi: 10.3390/jcm13237161.
2
Detection of genetic mutations in 855 cases of papillary thyroid carcinoma by next generation sequencing and its clinicopathological features.采用下一代测序技术检测 855 例甲状腺乳头状癌中的基因突变及其临床病理特征。
Diagn Pathol. 2024 Nov 15;19(1):146. doi: 10.1186/s13000-024-01573-3.
3
Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2).
甲状腺恶性肿瘤与皮肤淀粉样变性病:甲状腺髓样癌/多发性内分泌肿瘤 2 型(MEN2)中致病变体相关的要点。
Int J Mol Sci. 2024 Sep 10;25(18):9765. doi: 10.3390/ijms25189765.
4
The rapidly changing field of predictive biomarkers of non-small cell lung cancer.不断变化的非小细胞肺癌预测生物标志物领域。
Pathol Oncol Res. 2024 Jun 17;30:1611733. doi: 10.3389/pore.2024.1611733. eCollection 2024.
5
-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.- 改变的癌症——肿瘤非特异性生物学、诊断及靶向治疗活性综述
Cancers (Basel). 2023 Aug 17;15(16):4146. doi: 10.3390/cancers15164146.
6
Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study.RET基因改变的甲状腺癌患者护理中的挑战:一项多国混合方法研究。
Thyroid Res. 2023 Aug 14;16(1):22. doi: 10.1186/s13044-023-00166-4.
7
Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments.甲状腺髓样癌的个性化医疗:新兴治疗方法综述
J Pers Med. 2023 Jul 13;13(7):1132. doi: 10.3390/jpm13071132.
8
Precision oncology with selective RET inhibitor selpercatinib in -rearranged cancers.在RET重排癌症中使用选择性RET抑制剂塞尔帕替尼的精准肿瘤学。
Ther Adv Med Oncol. 2023 Jun 21;15:17588359231177015. doi: 10.1177/17588359231177015. eCollection 2023.
9
Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis.基于分子谱分析的甲状腺乳头状癌风险分层方法:机构分析。
BJS Open. 2023 May 5;7(3). doi: 10.1093/bjsopen/zrad029.
10
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications.从 AACR GENIE 数据库看肿瘤不可知的精准医学:临床意义。
Clin Cancer Res. 2023 Aug 1;29(15):2753-2760. doi: 10.1158/1078-0432.CCR-23-0090.